Jesus Ontañon

Jesus Ontañon

Auto-generated profile, based on publicly available information

Jesus Ontañon

Immunology Unit, Clinical Analysis Department Albacete University Hospital Complex Albacete Spain

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2021 in EBioMedicine
Verified
Journal Article
Open access
JOJesús Ontañón
Jesús Ontañón
JBJoaquín Blas
Joaquín Blas
Carlos de Cabo de la VegaCarlos de Cabo de la Vega
Carlos de Cabo de la Vega
CSCelia Santos
Celia Santos
ERElena Ruiz-Escribano
Elena Ruiz-Escribano
JSJavier Solera
Javier Solera
SARS-CoV-2 vaccines are an invaluable resource against COVID-19. Current vaccine shortage makes it necessary to prioritize distribution to the most appropriate segments of the population. This is a prospective cohort study of 63 health care workers (HCWs) from a General Hospital. We compared antibody responses to two doses of BNT162b2 mRNA COVID-19 vaccine between HCWs with previous SARS-CoV-2 infection (experienced HCWs) and HCWs without previous infection (naïve HCWs). Seven days after the first vaccine dose, HCWs with previous infection experienced a 126-fold increase in antibody levels (p50 AU). After the second dose, no significant increase in antibody levels was found in experienced HCWs, whereas in naïve HCWs, levels increased by 16-fold (p<0·001). Approximately two months post-vaccination, antibody levels were much lower in naïve HCWs compared to experienced HCWs (p<0·001). The study shows that at least ten months post-COVID-19 infection, the immune system is still capable of producing a rapid and powerful secondary antibody response following one single vaccine dose. Additionally, we found no further improvement in antibody response to the second dose in COVID-19 experienced HCWs. Nonetheless, two months later, antibody levels were still higher for experienced HCWs. These data suggest that immune memory persists in recovered individuals; therefore, the second dose of the COVID-19 vaccine in this group could be postponed until immunization of the remaining population is complete.

1 February 1999 in Transplantation Proceedings
Verified
Journal Article
Closed access
ALFREDO MINGUELA PURASALFREDO MINGUELA PURAS
ALFREDO MINGUELA PURAS
ATA Torı́o
A Torı́o
LML Marı́n
L Marı́n
FSF Sánchez-Bueno
F Sánchez-Bueno
AGA.M Garcı́a-Alonso
A.M Garcı́a-Alonso
MÁM.R Álvarez-López
M.R Álvarez-López



2 August 2024 in HLA
Verified
Journal Article
Closed access
LRLuis Alberto Marín Rubio
Luis Alberto Marín Rubio
JOJesús Ontañón
Jesús Ontañón